Jaso-Friedmann L, Leary J H, Evans D L
Department of Medical Microbiology, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
Mol Immunol. 1997 Aug-Sep;34(12-13):955-65. doi: 10.1016/s0161-5890(97)00086-2.
The recognition structure responsible for binding to conventional antigen on target cells has not previously been described for nonspecific cytotoxic cells (NCC) or for mammalian natural killer (NK) cells. Although several biochemical pathways may be available for initiation of the lytic cycle in NCC, evidence presented indicates that initial contact with a tumor cell or protozoan parasite is facilitated by recognition of a target antigen by a membrane protein of Mr 34,000 on NCC (NCC receptor protein, NCCRP-1). Binding to NCCRP-1 by monoclonal antibody 5C6, by target cell antigen or by cognate synthetic peptide initiates a signalling response leading to increased cytotoxicity. In the present study, three 20-mer microsequences were obtained from tryptic digests of purified NCCRP-1. Degenerate primers were synthesized (based on each peptide sequence) and were used for RT-PCR with mRNA purified from homogeneous NCC populations. An NCCRP-1 specific cDNA sequence was used to synthesize nondegenerate primers. These primers were used in a 5'/3' RACE PCR to obtain the entire NCCRP-1 specific cDNA. A deduced aa sequence consisted of 235 aa with a derived molecular weight of 30,628 Da. NCCRP-1 is proline rich (9%), has two glycosylation sites and 18% of all amino acids are potential phosphorylation sites (serine, threonine, tyrosine). The identity of the protein was confirmed by finding the previously microsequenced peptides in the derived sequence. Homology searches revealed that NCCRP-1 is a novel protein. Northern blot analysis of mRNA content from teleost NCC, B-cells and T-cells revealed only one band in NCC preparations. Functional studies demonstrated a decrease in membrane NCCRP-1 expression and inhibition of NCC cytotoxicity following treatment with NCCRP-1 anti-sense oligonucleotides. Treatment of NCC with sense oligonucleotides had no inhibitory effects on cytotoxicity. An algorithm predicting the membrane conformation of NCCRP-1 suggests one extracellular proline-rich domain, a transmembrane portion of 15 18 aa and a cytoplasmic tail composed of a high frequency of phosphorylation sites. Current studies suggest that NCC and NCCRP-1 may participate in innate resistance functions in teleost fish.
此前,尚未有关于非特异性细胞毒性细胞(NCC)或哺乳动物自然杀伤(NK)细胞中负责与靶细胞上常规抗原结合的识别结构的描述。尽管NCC中可能存在几种启动裂解周期的生化途径,但现有证据表明,NCC上一种分子量为34,000的膜蛋白(NCC受体蛋白,NCCRP - 1)对靶抗原的识别促进了与肿瘤细胞或原生动物寄生虫的初始接触。单克隆抗体5C6、靶细胞抗原或同源合成肽与NCCRP - 1的结合引发信号反应,导致细胞毒性增加。在本研究中,从纯化的NCCRP - 1的胰蛋白酶消化物中获得了三个20聚体微序列。合成了简并引物(基于每个肽序列),并将其用于从均一的NCC群体中纯化的mRNA的RT - PCR。使用NCCRP - 1特异性cDNA序列合成非简并引物。这些引物用于5'/3' RACE PCR以获得完整的NCCRP - 1特异性cDNA。推导的氨基酸序列由235个氨基酸组成,推导分子量为30,628 Da。NCCRP - 1富含脯氨酸(9%),有两个糖基化位点,所有氨基酸的18%是潜在的磷酸化位点(丝氨酸、苏氨酸、酪氨酸)。通过在推导序列中找到先前微测序的肽段,证实了该蛋白质的身份。同源性搜索显示NCCRP - 1是一种新型蛋白质。对硬骨鱼NCC、B细胞和T细胞的mRNA含量进行的Northern印迹分析显示,NCC制剂中只有一条带。功能研究表明,用NCCRP - 1反义寡核苷酸处理后,膜NCCRP - 1表达降低,NCC细胞毒性受到抑制。用正义寡核苷酸处理NCC对细胞毒性没有抑制作用。预测NCCRP - 1膜构象的算法表明,它有一个细胞外富含脯氨酸的结构域、一个由15 - 18个氨基酸组成的跨膜部分和一个由高频率磷酸化位点组成的细胞质尾巴。目前的研究表明,NCC和NCCRP - 1可能参与硬骨鱼的先天抗性功能。